Intestinal Metaplasia Clinical Trial
Official title:
Evaluation of Antral Biopsies Obtained in Normal Esophagogastroduodenoscopy: A Retrospective Cohort Study
Verified date | February 2024 |
Source | Sisli Hamidiye Etfal Training and Research Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Esophagogastroduodenoscopy (EGD) is commonly performed in patients presenting with abdominal pain and dyspeptic symptoms, serving as a valuable diagnostic and therapeutic tool. While various methods are available for biopsy sampling when mucosal pathology is observed during EGD, the practice of obtaining biopsies from endoscopically normal mucosa remains controversial. Although there is literature suggesting that routine biopsies from the antrum and duodenum for surveillance purposes increase costs, pathological findings can sometimes be detected in areas that appear normal on mucosal examination, leading to potential changes in treatment approach if biopsies are obtained. In this study, a retrospective evaluation of the prevalence of various pathologies detected in biopsies obtained from endoscopically normal mucosa in patients who underwent EGD was reported as normal.
Status | Completed |
Enrollment | 671 |
Est. completion date | February 21, 2024 |
Est. primary completion date | February 20, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 95 Years |
Eligibility | Inclusion Criteria: - Patients aged between 18-95 - Endoscopically normal esophagogastroduodenoscopy - Sampling biopsies must be obtained Exclusion Criteria: - History of upper gastrointestinal surgery - Abnormal endoscopic findings such as gastritis, ulcer, hiatal hernia, pyloric deformity, alkaline reflux - Not having biopsy |
Country | Name | City | State |
---|---|---|---|
Turkey | Sisli Hamidiye Etfal Research and Training Hospital | Istanbul |
Lead Sponsor | Collaborator |
---|---|
Sisli Hamidiye Etfal Training and Research Hospital |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Rate of abnormal histopathologic findings | Rate of abnormal histopathologic findings in patients with normal esophagogastroduodenoscopy and sampling biopsies obtained | 2 week after esophagogastroduodenoscopy | |
Secondary | Rate of intestinal metaplasia | Rate of intestinal metaplasia in patients with normal esophagogastroduodenoscopy and sampling biopsies obtained | 2 week after esophagogastroduodenoscopy | |
Secondary | Rates of gastritis severity and activity | Rate of gastritis severity and activity in patients with normal esophagogastroduodenoscopy and sampling biopsies obtained | 2 week after esophagogastroduodenoscopy | |
Secondary | Rate of Helicobacter Pylori positivity | Rate of Helicobacter Pylori positivity in patients with normal esophagogastroduodenoscopy and sampling biopsies obtained | 2 week after esophagogastroduodenoscopy |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03554356 -
Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus (NO FEAR-BE)
|
N/A | |
Recruiting |
NCT01398579 -
Comparison Between Probe-based Confocal Laser Endomicroscopy, White-light Endoscopy and Virtual Chromoendoscopy
|
Phase 1 | |
Completed |
NCT01614418 -
Radiofrequency Ablation for Gastric Metaplasia and Dysplasia
|
Phase 1/Phase 2 | |
Completed |
NCT06282484 -
A Study on the Relationship Between Gastric Xanthoma and Gastric Cancer and Precancerous Lesions
|
||
Not yet recruiting |
NCT06085677 -
The Gastric HormonE BioMarkers of Preneoplastic Lesions Study
|
||
Completed |
NCT01024621 -
Confocal Laser Endomicroscopy for the Detection of Gastric Intestinal Metaplasia: a Randomized Controlled Trial
|
N/A | |
Terminated |
NCT05579444 -
Systems Biology of Gastrointestinal and Related Diseases
|
||
Recruiting |
NCT04331951 -
Sensitivity of Targeted Biopsy Within Sydney Protocol for GIM
|
N/A | |
Completed |
NCT03188406 -
Gastric Cancer Precursor Lesions (GCPL) Study
|
||
Recruiting |
NCT05053945 -
Helicobacter Pylori, Atrophic Gastritis and Intestinal Metaplasia Registry and Prospective Study
|
||
Completed |
NCT02075905 -
Stratifying Risk in Barrett's Esophagus: A Pilot Study for Biomarker-based Patient Management
|
N/A | |
Completed |
NCT01374074 -
Racial Disparity in Barrett's Esophagus
|
N/A | |
Recruiting |
NCT02457624 -
Gastric Cancer Screening Quality Improvement System Establishment
|
N/A | |
Recruiting |
NCT05818072 -
The Prevalence, Risk Factors and Optimal Biopsy Protocol of BE
|
N/A | |
Completed |
NCT04296513 -
Diagnosis of Gastritis, H. Pylori Infection and Atrophic Gastritis in Dyspeptic Patients
|
||
Completed |
NCT01896310 -
New Classification of Stomach Using Probe-based Confocal Laser Endomicroscopy
|
N/A | |
Completed |
NCT01373125 -
Is the Neosquamous Epithelium "Normal" Following Endoscopic Ablation of Dysplastic Barrett's Esophagus?
|
N/A | |
Completed |
NCT03976739 -
Study on the Effect of Bile Reflux on Gastric Cancer and Its Precancerous Lesions: a Cross-sectional Study.
|
||
Recruiting |
NCT04054713 -
Acetic Acid for the Detection of Esophageal Neoplasms
|
N/A | |
Terminated |
NCT02788214 -
Helicobacter Pylori Genome Project (HpGP)
|